Guiding Question for Field Building: what integrated approaches can this community develop to overcome existing challenges and unlock the full potential of human-machine coexistence?

Join us to explore neurotech progress for the benefit of life.

Agenda:
3:00-3:30pm Claire short:  Overview of BCI and neuro-applications in AI safety and the Whole Brain Emulation space

3:30-4:00pm Catalin Mitelut: Re-framing the experimental, computational and theoretical challenges in Whole-Brain-Emulation from an agency neuroscience perspective

4:00-4:30pm Alex Feerst: Legal Developments Related to BCI

4:30-5:00pm Michael Andregg:  hi-fi + lo-fi human emulation

5:30-6pm Thorsten O Zander: Neuroadaptive AI

5:30- 6:30pm: Claire Short: Starting a BCI/AI lab: what research do you want to see in the BCI space? What data would create valuable steps forward?

Breakthroughs in biotech, neuroscience and artificial intelligence converge, rapidly opening new avenues to progress in Neurotech. Ambitious projects are emerging in the field, and may soon allow us to augment ourselves and unlock unexplored potentials for the human mind. Yet, various challenges remain in the way of broader development and adoption. At the same time, AGI timelines are rapidly shortening, and Neurotech could present differential technology development pathways to develop AGI - calling for rapid capability ramp up in the field.

Thus, this event focuses on the latest developments in neurotech with a particular focus on highlighting their potential critical role for AI safety and human-machine cooperation.

Our goal is to surface frameworks for guiding this interdisciplinary field toward beneficial outcomes.

Progress talks, technical deep dives, and salons sessions will survey progress to date, highlighting science and tech opportunities, mapping the technical and legal bottlenecks in WBE and BCI, evaluating how these technologies may enhance human capabilities and safety in a globally scalable way, surfacing differential technology development paths for neurotech in relation to AGI, and from there, developing strategies for widespread adoption of neurotechnologies. From these discussions we will derive which areas of the neurotech space may require increased funding and field-building efforts.